Intravitreal Bevacizumab to Treat Acute Central Serous Chorioretinopathy: Short-Term Effect

2009 
Aims: To report the beneficial effect of intravitreal bevacizumab (Avastin) injection in patients with acute central serous chorioretinopathy. Methods: Ten eyes o
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    32
    References
    55
    Citations
    NaN
    KQI
    []